352 related articles for article (PubMed ID: 10100082)
21. Combined neutral endopeptidase and angiotensin-converting enzyme inhibition in heart failure: role of natriuretic peptides and angiotensin II.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
J Cardiovasc Pharmacol; 1998 Jan; 31(1):116-25. PubMed ID: 9456286
[TBL] [Abstract][Full Text] [Related]
22. Dose-response study of atrial natriuretic peptide bolus injection in healthy man.
Eiskjaer H; Pedersen EB
Eur J Clin Invest; 1993 Jan; 23(1):37-45. PubMed ID: 8383057
[TBL] [Abstract][Full Text] [Related]
23. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
24. Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme inhibition on diuretic therapy in experimental congestive heart failure.
Cataliotti A; Boerrigter G; Chen HH; Jougasaki M; Costello LC; Tsuruda T; Lee SC; Malatino LS; Burnett JC
Circulation; 2002 Feb; 105(5):639-44. PubMed ID: 11827932
[TBL] [Abstract][Full Text] [Related]
25. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
[TBL] [Abstract][Full Text] [Related]
26. Renal and hormonal effects of chronic inhibition of neutral endopeptidase (EC 3.4.24.11) in normal man.
O'Connell JE; Jardine AG; Davies DL; McQueen J; Connell JM
Clin Sci (Lond); 1993 Jul; 85(1):19-26. PubMed ID: 8149689
[TBL] [Abstract][Full Text] [Related]
27. Relationship of the renin-angiotensin system and systemic arterial pressure to sodium excretion during atrial natriuretic peptide infusion in men.
Grandis DJ; Uretsky BF; Verbalis JG; Chong TK; Puschett JB
Am J Hypertens; 1992 Nov; 5(11):793-9. PubMed ID: 1457079
[TBL] [Abstract][Full Text] [Related]
28. Natriuretic response to neutral endopeptidase inhibition is blunted by enalapril in healthy men.
Motwani JG; Lang CC; Cramb G; Struthers AD
Hypertension; 1995 Apr; 25(4 Pt 1):637-42. PubMed ID: 7721409
[TBL] [Abstract][Full Text] [Related]
29. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
30. Hypotensive and natriuretic effects of RB 105, a new dual inhibitor of angiotensin converting enzyme and neutral endopeptidase in hypertensive rats.
Gonzalez Vera W; Fournié-Zaluski MC; Pham I; Laboulandine I; Roques BP; Michel JB
J Pharmacol Exp Ther; 1995 Jan; 272(1):343-51. PubMed ID: 7815350
[TBL] [Abstract][Full Text] [Related]
31. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
[TBL] [Abstract][Full Text] [Related]
32. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
[TBL] [Abstract][Full Text] [Related]
33. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
Biollaz J; Nussberger J; Porchet M; Brunner-Ferber F; Otterbein ES; Gomez H; Waeber B; Brunner HR
Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of both angiotensin-converting enzyme and neutral endopeptidase by S21402 (RB105) in rats with experimental myocardial infarction.
Gonzalez W; Beslot F; Laboulandine I; Fournié-Zaluski MC; Roques BP; Michel JB
J Pharmacol Exp Ther; 1996 Aug; 278(2):573-81. PubMed ID: 8768706
[TBL] [Abstract][Full Text] [Related]
35. Beneficial renal and hemodynamic effects of omapatrilat in mild and severe heart failure.
Troughton RW; Rademaker MT; Powell JD; Yandle TG; Espiner EA; Frampton CM; Nicholls MG; Richards AM
Hypertension; 2000 Oct; 36(4):523-30. PubMed ID: 11040230
[TBL] [Abstract][Full Text] [Related]
36. Interaction of angiotensin converting enzyme inhibition and atrial natriuretic factor.
Richards AM; Rao G; Espiner EA; Yandle T
Hypertension; 1989 Mar; 13(3):193-9. PubMed ID: 2537795
[TBL] [Abstract][Full Text] [Related]
37. Combined endopeptidase inhibition and adrenomedullin in sheep with experimental heart failure.
Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
Hypertension; 2002 Jan; 39(1):93-8. PubMed ID: 11799085
[TBL] [Abstract][Full Text] [Related]
38. Physiologic consequences of vasopeptidase inhibition in humans: effect of sodium intake.
Azizi M; Lamarre-Cliche M; Labatide-Alanore A; Bissery A; Guyene TT; Ménard J
J Am Soc Nephrol; 2002 Oct; 13(10):2454-63. PubMed ID: 12239234
[TBL] [Abstract][Full Text] [Related]
39. Effects of renal neutral endopeptidase inhibition on sodium excretion, renal hemodynamics and neurohormonal activation in patients with congestive heart failure.
Kimmelstiel CD; Perrone R; Kilcoyne L; Souhrada J; Udelson J; Smith J; de Bold A; Griffith J; Konstam MA
Cardiology; 1996; 87(1):46-53. PubMed ID: 8631044
[TBL] [Abstract][Full Text] [Related]
40. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
Eiskjaer H; Nielsen CB; Pedersen EB
J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
